170 related articles for article (PubMed ID: 26840222)
1. Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours.
Cemazar M; Ambrozic Avgustin J; Pavlin D; Sersa G; Poli A; Krhac Levacic A; Tesic N; Lampreht Tratar U; Rak M; Tozon N
Vet Comp Oncol; 2017 Jun; 15(2):641-654. PubMed ID: 26840222
[TBL] [Abstract][Full Text] [Related]
2. The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision.
Lowe R; Gavazza A; Impellizeri JA; Soden DM; Lubas G
Vet Comp Oncol; 2017 Sep; 15(3):775-784. PubMed ID: 27001443
[TBL] [Abstract][Full Text] [Related]
3. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: Comparison of intratumoral and peritumoral application of IL-12.
Lampreht Tratar U; Milevoj N; Cemazar M; Znidar K; Ursic Valentinuzzi K; Brozic A; Tomsic K; Sersa G; Tozon N
Int Immunopharmacol; 2023 Jul; 120():110274. PubMed ID: 37216797
[TBL] [Abstract][Full Text] [Related]
4. Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
Cicchelero L; Denies S; Haers H; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Vet Comp Oncol; 2017 Dec; 15(4):1187-1205. PubMed ID: 27506827
[TBL] [Abstract][Full Text] [Related]
5. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
[TBL] [Abstract][Full Text] [Related]
6. Electrochemotherapy compared to surgery for treatment of canine mast cell tumours.
Kodre V; Cemazar M; Pecar J; Sersa G; Cor A; Tozon N
In Vivo; 2009; 23(1):55-62. PubMed ID: 19368125
[TBL] [Abstract][Full Text] [Related]
7. Numerical model of dog mast cell tumor treated by electrochemotherapy.
Suzuki DO; Anselmo J; de Oliveira KD; Freytag JO; Rangel MM; Marques JL; Ramos A
Artif Organs; 2015 Feb; 39(2):192-7. PubMed ID: 25041415
[TBL] [Abstract][Full Text] [Related]
8. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats.
Tozon N; Sersa G; Cemazar M
Anticancer Res; 2001; 21(4A):2483-8. PubMed ID: 11724311
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in dogs treated with electrochemotherapy and/or interleukin-12 gene electrotransfer.
Milevoj N; Tozon N; Licen S; Lampreht Tratar U; Sersa G; Cemazar M
Vet Med Sci; 2020 Aug; 6(3):290-298. PubMed ID: 31910331
[TBL] [Abstract][Full Text] [Related]
10. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer.
Sersa G; Teissie J; Cemazar M; Signori E; Kamensek U; Marshall G; Miklavcic D
Cancer Immunol Immunother; 2015 Oct; 64(10):1315-27. PubMed ID: 26067277
[TBL] [Abstract][Full Text] [Related]
11. Electrochemotherapy in treatment of canine oral non-tonsillar squamous cell carcinoma. A case series report.
Simčič P; Lowe R; Granziera V; Pierini A; Torrigiani F; Lubas G
Vet Comp Oncol; 2020 Sep; 18(3):428-432. PubMed ID: 31419028
[TBL] [Abstract][Full Text] [Related]
12. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
13. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs.
Spugnini EP; Vincenzi B; Citro G; Dotsinsky I; Mudrov T; Baldi A
J Vet Intern Med; 2011; 25(2):407-11. PubMed ID: 21382075
[TBL] [Abstract][Full Text] [Related]
15. Masitinib mesylate for metastatic and non-resectable canine cutaneous mast cell tumours.
Smrkovski OA; Essick L; Rohrbach BW; Legendre AM
Vet Comp Oncol; 2015 Sep; 13(3):314-21. PubMed ID: 23845124
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.
Cutrera J; Torrero M; Shiomitsu K; Mauldin N; Li S
Methods Mol Biol; 2008; 423():319-25. PubMed ID: 18370210
[TBL] [Abstract][Full Text] [Related]
17. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.
Tevz G; Kranjc S; Cemazar M; Kamensek U; Coer A; Krzan M; Vidic S; Pavlin D; Sersa G
J Gene Med; 2009 Dec; 11(12):1125-37. PubMed ID: 19777440
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.
Reed SD; Fulmer A; Buckholz J; Zhang B; Cutrera J; Shiomitsu K; Li S
Cancer Gene Ther; 2010 Jul; 17(7):457-64. PubMed ID: 20150931
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.
Sedlar A; Dolinsek T; Markelc B; Prosen L; Kranjc S; Bosnjak M; Blagus T; Cemazar M; Sersa G
Radiol Oncol; 2012 Dec; 46(4):302-11. PubMed ID: 23412658
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Nucleosome, Ferritin and LDH Levels in Blood with Clinical Response before and after Electrochemotherapy Combined with IL-12 Gene Electrotransfer for the Treatment of Mast Cell Tumours in Dogs.
Vilfan M; Lampreht Tratar U; Milevoj N; Nemec Svete A; Čemažar M; Serša G; Tozon N
Animals (Basel); 2024 Jan; 14(3):. PubMed ID: 38338081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
